Moberg Pharma: Delivers its fourth license agreement for MOB-015
Today's announced agreement with DongKoo provides a commercial presence in the relatively large (~USD 40m) and fast-growing South Korean topical nail fungus market. DongKoo seems to be a perfect distribution partner for MOB-015, with a strong presence at the dermatology clinics.